Release Date: 24/09/13 16:48 Summary: Appendix 3Y - Change of Director's Interest Notice Price Sensitive: No Download Document 71.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%